Global Deep Brain Stimulation Market Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5000$10000

Deep Brain Stimulation Market Share Revenue and Growth Rate to Increase During Forecast Year 2020-2030

SKU: FPG0568 Category: Tag:

Description

Deep Brain Stimulation Market

Market Overview
Deep brain stimulation is a surgery that involves implanting a device that transmits a signal to the parts of the brain that control movement. DBS helps to alleviate the symptoms of stiffness, sluggishness, and walking difficulties caused by neurological illnesses such dystonia, Parkinson’s disease, and essential tremor. Patients who have not responded to medications for at least five years might consider this treatment. Furthermore, the FDA has authorized this medication for individuals who are unable to undergo epilepsy surgery, which involves separating or removing the region of the brain that causes seizures. As a result, the increased frequency of neurological diseases such as Alzheimer’s and Parkinson’s disease is a primary driver of market expansion.

Deep Brain Stimulation Market: Key Players
Abbott (St. Jude Medical)
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Medtronic
Boston Scientific Corporation
Aleva Neurotherapeutics S.A.
Nexstim
LivaNova PLC
Neuropace Inc.
Renishaw PLC
Beijing PINS Medical Co. Ltd
Fisher Wallace

Growth Factor
Rapidly aging population
According to the Globe Ageing 2019 study, there were around 703 million people aged 65 and up in the world in 2019. In 2050, this population is expected to increase to 1.5 billion. Furthermore, by 2050, one in every six individuals on the planet will be beyond the age of 65, up from one in every eleven in 2019. The older population is expected to grow, and this group is more susceptible to neurological problems, which will drive the market in the near future.
Segmentation
By Stimulation Type
Subthalamic DBS
Globus Pallidus DBS
Thalamic DBS
Pedunculopontine Nucleus DBS
By Product
Single Channel Deep Brain Stimulator
Dual Channel Deep Brain Stimulator
By Application
Parkinson’s Disease (PD)
Epilepsy
Dystonia
Obsessive Compulsive Disorder (OCD)
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Neurological Centers
Others
Deep Brain Stimulation Market Dynamics
Deep Brain Stimulation Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints

Recent News Related to Market
In February 2019, Medtronic announced the availability of Deep Brain Simulation (DBS) in the United States for medically resistant epilepsy. Such a unique offering will help the firm expand its consumer base and increase income.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Deep Brain Stimulation Market growth?
Which segment accounted for the largest Deep Brain Stimulation Market share?
Who are the key players in the Deep Brain Stimulation Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in Our reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents 1. Executive Summary 2. Global Deep Brain Stimulation Market 2.1. Product Overview 2.2. Market Definition 2.3. Segmentation 2.4. Assumptions and Acronyms 3. Research Methodology 3.1. Research Objectives 3.2. Primary Research 3.3. Secondary Research 3.4. Forecast Model 3.5. Market Size Estimation 4. Average Pricing Analysis 5. Macro-Economic Indicators 6. Market Dynamics 6.1. Growth Drivers 6.2. Restraints 6.3. Opportunity 6.4. Trends 7. Correlation & Regression Analysis 7.1. Correlation Matrix 7.2. Regression Matrix 8. Recent Development, Policies & Regulatory Landscape 9. Risk Analysis 9.1. Demand Risk Analysis 9.2. Supply Risk Analysis 10. Global Deep Brain Stimulation Market Analysis 10.1. Porters Five Forces 10.1.1. Threat of New Entrants 10.1.2. Bargaining Power of Suppliers 10.1.3. Threat of Substitutes 10.1.4. Rivalry 10.2. PEST Analysis 10.2.1. Political 10.2.2. Economic 10.2.3. Social 10.2.4. Technological 11. Global Deep Brain Stimulation Market 11.1. Market Size & forecast, 2020A-2030F 11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12. Global Deep Brain Stimulation Market: Market Segmentation 12.1. By Regions 12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.3. Asia-Pacific: (China, India, Japan, South Korea, Australia, Thailand, Malaysia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.4. Latin America: (Brazil, Mexico, Argentina, Colombia, Chile and Venezuela), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.5. MEA: (South Africa, Saudi Arabia, UAE, Turkey and Iran), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.2. By Stimulation Type: Market Share (2020-2030F) 12.2.1. Subthalamic DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.2.2. Globus Pallidus DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.2.3. Thalamic DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.2.4. Pedunculopontine Nucleus DBS, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.3. By Product: Market Share (2020-2030F) 12.3.1. Single Channel Deep Brain Stimulator, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.3.2. Dual Channel Deep Brain Stimulator, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4. By Application: Market Share (2020-2030F) 12.4.1. Parkinson's Disease (PD), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4.2. Epilepsy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4.3. Dystonia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4.4. Obsessive Compulsive Disorder (OCD), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.5. By End-User: Market Share (2020-2030F) 12.5.1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.5.2. Ambulatory Surgical Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.5.3. Neurological Centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.5.4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 13. Company Profile 13.1. Abbott Laboratories 13.1.1. Company Overview 13.1.2. Company Total Revenue (Financials) 13.1.3. Market Potential 13.1.4. Global Presence 13.1.5. Key Performance Indicators 13.1.6. SWOT Analysis 13.1.7. Product Launch 13.2. Medtronic 13.3. Boston Scientific Corporation 13.4. Aleva Neurotherapeutics S.A. 13.5. Nexstim 13.6. LivaNova PLC 13.7. Neuropace Inc. 13.8. Renishaw PLC 13.9. Beijing PINS Medical Co. Ltd 13.10. Fisher Wallace Consultant Recommendation **The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

Reviews

There are no reviews yet.

Be the first to review “Global Deep Brain Stimulation Market Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030”